Michael C Thigpen
Overview
Explore the profile of Michael C Thigpen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
2375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chirwa L, Johnson J, Niska R, Segolodi T, Henderson F, Rose C, et al.
AIDS
. 2013 Dec;
28(2):223-6.
PMID: 24361682
We examined CD4 cell count and plasma viral load patterns among Botswana TDF/FTC Oral HIV Prophylaxis Trial (TDF2 study) participants who seroconverted, comparing participants assigned to receive tenofovir/emtricitabine with participants...
12.
Thigpen M, Rose C, Paxton L
N Engl J Med
. 2013 Jan;
368(1):82-3.
PMID: 23281985
No abstract available.
13.
Hudgens M, Taha T, Omer S, Jamieson D, Lee H, Mofenson L, et al.
Clin Infect Dis
. 2012 Sep;
56(1):131-9.
PMID: 22997212
Background: In resource-limited settings, mothers infected with human immunodeficiency virus type 1 (HIV-1) face a difficult choice: breastfeed their infants but risk transmitting HIV-1 or not breastfeed their infants and...
14.
Thigpen M, Kebaabetswe P, Paxton L, Smith D, Rose C, Segolodi T, et al.
N Engl J Med
. 2012 Jul;
367(5):423-34.
PMID: 22784038
Background: Preexposure prophylaxis with antiretroviral agents has been shown to reduce the transmission of human immunodeficiency virus (HIV) among men who have sex with men; however, the efficacy among heterosexuals...
15.
Taha T, Hoover D, Chen S, Kumwenda N, Mipando L, Nkanaunena K, et al.
Clin Infect Dis
. 2011 Aug;
53(4):388-95.
PMID: 21810754
Background: We assessed morbidity rates during short intervals that accompanied weaning and cumulative mortality among HIV-exposed, uninfected infants enrolled in the postexposure prophylaxis of infants in Malawi (PEPI-Malawi) trial. Methods:...
16.
Thigpen M, Whitney C, Messonnier N, Zell E, Lynfield R, Hadler J, et al.
N Engl J Med
. 2011 May;
364(21):2016-25.
PMID: 21612470
Background: The rate of bacterial meningitis declined by 55% in the United States in the early 1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine for infants was introduced....
17.
Zeh C, Weidle P, Nafisa L, Lwamba H, Okonji J, Anyango E, et al.
PLoS Med
. 2011 Apr;
8(3):e1000430.
PMID: 21468304
Background: Nevirapine and lamivudine given to mothers are transmitted to infants via breastfeeding in quantities sufficient to have biologic effects on the virus; this may lead to an increased risk...
18.
Thomas T, Masaba R, Borkowf C, Ndivo R, Zeh C, Misore A, et al.
PLoS Med
. 2011 Apr;
8(3):e1001015.
PMID: 21468300
Background: Effective strategies are needed for the prevention of mother-to-child HIV transmission (PMTCT) in resource-limited settings. The Kisumu Breastfeeding Study was a single-arm open label trial conducted between July 2003...
19.
Fogel J, Li Q, Taha T, Hoover D, Kumwenda N, Mofenson L, et al.
Clin Infect Dis
. 2011 Apr;
52(8):1069-76.
PMID: 21460326
Background: The World Health Organization currently recommends initiation of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV)-infected lactating women with CD4+ cell counts <350 cells/μL or stage 3...
20.
Taha T, Li Q, Hoover D, Mipando L, Nkanaunena K, Thigpen M, et al.
J Acquir Immune Defic Syndr
. 2011 Mar;
57(4):319-25.
PMID: 21423025
Background: This analysis updates and extends efficacy estimates of the PEPI-Malawi trial through age 24 months at study completion in September 2009. Methods: Infants of breastfeeding HIV-infected women were randomized...